The global sterile antimicrobial gel market was valued at approximately USD 1.44 billion in 2023 and is expected to reach around USD 3.05 billion by 2034. This represents a robust compound annual growth rate (CAGR) of 7.05% from 2024 to 2034. The growing demand for sterile antimicrobial gels can be attributed to their essential role in preventing infections, particularly in post-surgical care, as well as in treating chronic skin ulcers, traumatic wounds, and post-operative wounds. These gels are favored for their unique combination of biocompatibility, wound healing capabilities, and disinfectant properties, making them a crucial tool in modern medical treatments.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5308
In September 2024, the U.S. Department of Health and Human Services (HHS) announced funding for the project “Transforming Antibiotic R&D with Generative AI to Stop Emerging Threats (TARGET).” This initiative, supported by the Advanced Research Projects Agency for Health, aims to enhance the development of new antibiotics using AI technology.
The G7 Finance and Health Ministers have pledged to strengthen efforts to combat antimicrobial resistance (AMR) by implementing existing strategies, addressing the market failure of antibiotics, and creating economic conditions to preserve the effectiveness of critical antibiotics.
In November 2023, the Food and Drug Administration (FDA) proposed new requirements for premarket approval applications (PMA) for certain wound dressings, including creams, gels, ointments, solid wound dressings, and liquid wound washes containing medically significant antimicrobials.
Asia Pacific is experiencing the fastest growth in the sterile antimicrobial gel market, driven by factors such as a growing population, increasing medical tourism, and a rising number of traumatic injuries. China leads the region with its large population, technological advancements, and expanding demand for healthcare products and services. Germany is also contributing to market growth with its focus on developing antimicrobial wound gel products aimed at improving patient outcomes. Leading companies in the market are expanding their product offerings and engaging in strategic activities, such as new product launches, investments, mergers and acquisitions, and collaborations, to strengthen their global presence. These efforts help companies provide cost-effective solutions, ensuring their survival in a competitive market.
North America held the largest share of the sterile antimicrobial gel market in 2023, due to a high elderly population and increased rates of conditions like diabetes, burns, and traffic accidents. In Europe, the United Kingdom is at the forefront of the market, with its strong medical-focused healthcare services and solutions. Manufacturers in the region are focusing on reducing operational costs as a key business strategy. The UK-based Smith & Nephew Plc, a member of the FTSE 100 index, is a major player in the market. In 2019, they acquired Rotation Medical Inc. to advance their tissue regeneration techniques for repairing rotator cuff injuries. Research and development remain a priority for these companies as they work to develop trustworthy medical products. According to a 2020 NCBI study, approximately 40 to 50 million medical procedures are performed annually in the U.S., highlighting the growing demand for sterile antimicrobial products due to an increase in surgical procedures and hospital-acquired infections.
Product Insights The sterile antimicrobial gel market is divided into categories such as silver dressings, povidone-iodine dressings, PHMB dressings, and others. In 2023, silver wound dressings held the largest market share. These dressings are highly effective in antimicrobial wound care, with silver as the key active ingredient. Available in various forms, including foam, gauze, hydrocolloid, and alginate, silver wound dressings are particularly beneficial for chronic wounds, such as pressure ulcers and diabetic foot ulcers, which are highly susceptible to infection.
Application Insights The market for antimicrobial wound dressings for chronic wounds was the largest in 2023. This includes treatments for conditions like pressure ulcers and lower extremity ulcers. Due to the high morbidity and mortality rates associated with chronic wounds, as well as growing public health concerns, the demand for these products is expected to continue to rise.
End-User Insights Hospitals led the market in 2023 due to the adoption of advanced tools and technologies for diagnosis, wound monitoring, and fast healing solutions. In recent years, hospitals have also focused on specialized home care services and dedicated wound care departments to manage and treat infectious conditions in patients.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/sterile-antimicrobial-gel-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5308
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
Vein Finder Market Growth and Forecast (2024 - 2032) The global vein finder market is projected to expand from USD… Read More
Bone Densitometer Market Overview Growth, Trends and Future Projections The global bone densitometer market was valued at USD 308.33 million… Read More
Global Market for Autoimmune Hepatitis Diagnosis and Treatment Projected Growth and Trends The global market for autoimmune hepatitis diagnosis and… Read More
Hemato-Oncology Testing Market Growth and Key Players The global hemato-oncology testing market was valued at $3.17 billion in 2023 and… Read More
Synovial Sarcoma Treatment Market Insights The synovial sarcoma treatment market was valued at USD 822.74 million in 2023 and is… Read More
Chronic Lower Back Pain Market Growth, Future Trends and Forecast The chronic lower back pain market was valued at $2.46… Read More